imiquimod has been researched along with Stevens-Johnson Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Banney, L; Buzacott, K; Malla, U; Tedman, A; Vasanthakumar, L | 1 |
| Sidbury, R | 1 |
| Arndt, KA; Dover, JS; Lipper, GM | 1 |
1 review(s) available for imiquimod and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
What's new in pediatric dermatology: update for the pediatrician.
Topics: Adjuvants, Immunologic; Aminoquinolines; Child; Clinical Trials as Topic; Dermatitis, Atopic; Hemangioma; Humans; Imiquimod; Immunoglobulins; Immunologic Factors; Immunosuppressive Agents; Infant; Molluscum Contagiosum; Skin; Skin Diseases; Stevens-Johnson Syndrome; Tacrolimus; Vitiligo; Warts | 2004 |
2 other study(ies) available for imiquimod and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Stevens-Johnson syndrome due to topical imiquimod 5%.
Topics: Administration, Topical; Aged; Blister; Conjunctivitis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Imiquimod; Oral Ulcer; Stevens-Johnson Syndrome | 2020 |
Recent therapeutic advances in dermatology.
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Dermatitis; Dermatology; Humans; Imiquimod; Interferon Inducers; Keratolytic Agents; Stevens-Johnson Syndrome; Tacrolimus | 2000 |